NASDAQ
iTeos Therapeutics, Inc. (ITOS) has a price/sales ratio of 8.88x as of Friday, May 22, 2026. This represents a 7.58% decrease compared to its 12-month average of 9.61x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.